These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 24928953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial using bosentan to enhance the impact of exercise training in subjects with type 2 diabetes mellitus.
    Schreuder TH, Duncker DJ, Hopman MT, Thijssen DH.
    Exp Physiol; 2014 Nov; 99(11):1538-47. PubMed ID: 25172889
    [Abstract] [Full Text] [Related]

  • 3. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
    Rafnsson A, Shemyakin A, Pernow J.
    Life Sci; 2014 Nov 24; 118(2):435-9. PubMed ID: 24607773
    [Abstract] [Full Text] [Related]

  • 4. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
    Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V.
    Diabetologia; 2002 Mar 24; 45(3):420-6. PubMed ID: 11914748
    [Abstract] [Full Text] [Related]

  • 5. The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial.
    Rafnsson A, Böhm F, Settergren M, Gonon A, Brismar K, Pernow J.
    Diabetologia; 2012 Mar 24; 55(3):600-7. PubMed ID: 22200728
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF, Lieps D, Schatz H, Pfohl M.
    Microvasc Res; 2008 May 24; 76(1):61-5. PubMed ID: 18448131
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improved brachial artery shear patterns and increased flow-mediated dilatation after low-volume high-intensity interval training in type 2 diabetes.
    Ghardashi Afousi A, Izadi MR, Rakhshan K, Mafi F, Biglari S, Gandomkar Bagheri H.
    Exp Physiol; 2018 Sep 24; 103(9):1264-1276. PubMed ID: 29932275
    [Abstract] [Full Text] [Related]

  • 20. Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure.
    Berger R, Stanek B, Hülsmann M, Frey B, Heher S, Pacher R, Neunteufl T.
    Circulation; 2001 Feb 20; 103(7):981-6. PubMed ID: 11181473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.